DK1364959T3 - Krystallinske former af pyrimidinnukleosidderivater - Google Patents

Krystallinske former af pyrimidinnukleosidderivater

Info

Publication number
DK1364959T3
DK1364959T3 DK02711347T DK02711347T DK1364959T3 DK 1364959 T3 DK1364959 T3 DK 1364959T3 DK 02711347 T DK02711347 T DK 02711347T DK 02711347 T DK02711347 T DK 02711347T DK 1364959 T3 DK1364959 T3 DK 1364959T3
Authority
DK
Denmark
Prior art keywords
crystalline forms
pyrimidine nucleoside
nucleoside derivatives
pyrimidine
derivatives
Prior art date
Application number
DK02711347T
Other languages
Danish (da)
English (en)
Inventor
Takashi Takita
Keiichi Ohtsuka
Eiji Numagami
Susumu Harashima
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Application granted granted Critical
Publication of DK1364959T3 publication Critical patent/DK1364959T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK02711347T 2001-02-09 2002-02-06 Krystallinske former af pyrimidinnukleosidderivater DK1364959T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001033128 2001-02-09
PCT/JP2002/000986 WO2002064609A1 (fr) 2001-02-09 2002-02-06 Cristaux de derive de nucleoside de pyrimidine

Publications (1)

Publication Number Publication Date
DK1364959T3 true DK1364959T3 (da) 2007-06-04

Family

ID=18896929

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02711347T DK1364959T3 (da) 2001-02-09 2002-02-06 Krystallinske former af pyrimidinnukleosidderivater

Country Status (21)

Country Link
EP (1) EP1364959B1 (ru)
JP (2) JP3748536B2 (ru)
KR (1) KR100679904B1 (ru)
CN (1) CN100408591C (ru)
AT (1) ATE361929T1 (ru)
AU (1) AU2002230164B2 (ru)
BR (2) BR0207102A (ru)
CA (1) CA2437994C (ru)
CY (1) CY1106685T1 (ru)
CZ (1) CZ303241B6 (ru)
DE (1) DE60220024T2 (ru)
DK (1) DK1364959T3 (ru)
ES (1) ES2286237T3 (ru)
HU (1) HU229294B1 (ru)
IL (2) IL157216A0 (ru)
MX (1) MXPA03007123A (ru)
NZ (1) NZ527393A (ru)
PT (1) PT1364959E (ru)
RU (1) RU2256666C2 (ru)
WO (1) WO2002064609A1 (ru)
ZA (1) ZA200306121B (ru)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2081419B1 (en) 1999-09-02 2013-08-07 Ibiden Co., Ltd. Printed circuit board and method of manufacturing printed circuit board
GB0526419D0 (en) * 2005-12-23 2006-02-08 Cyclacel Ltd Formulation
GB0625283D0 (en) 2006-12-19 2007-01-24 Cyclacel Ltd Combination
JP5066737B2 (ja) * 2007-04-06 2012-11-07 大鵬薬品工業株式会社 シチジン誘導体を含有する持続静脈内投与用抗腫瘍剤
US8124593B2 (en) 2007-11-05 2012-02-28 Cyclacel Limited Methods of treatment using sapacitabine
GB0808357D0 (en) 2008-05-08 2008-06-18 Cyclacel Ltd Process
CA2725295C (en) 2008-06-09 2016-11-08 Cyclacel Limited Combination of sapacitabine (cndac) and dna methyltransferase inhibitors such as decitabine and procaine
ES2743691T3 (es) 2011-04-14 2020-02-20 Cyclacel Ltd Régimen de dosis para sapacitabina y decitabina en combinación para tratar la leucemia mieloide aguda
BR112014022789B1 (pt) * 2012-03-15 2022-04-19 Celgene Car Llc Formas sólidas de um inibidor de quinase de receptor do fator de crescimento epidérmico, composição farmacêutica e usos do mesmo
WO2016144660A1 (en) 2015-03-09 2016-09-15 W.R. Grace & Co.-Conn. Crystalline form of nicotinamide riboside
WO2019126482A1 (en) 2017-12-22 2019-06-27 Elysium Health, Inc. Crystalline forms of nicotinamide riboside chloride

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI105556B (fi) * 1991-09-30 2000-09-15 Sankyo Co Menetelmä lääkeaineina käyttökelpoisten pyrimidiiniukleosidijohdannaisten valmistamiseksi, joilla on kasvaimen vastaista vaikutusta

Also Published As

Publication number Publication date
ATE361929T1 (de) 2007-06-15
CN1501939A (zh) 2004-06-02
BR0207102A (pt) 2004-01-27
KR100679904B1 (ko) 2007-02-07
JP4356998B2 (ja) 2009-11-04
JP2002308895A (ja) 2002-10-23
HUP0303159A3 (en) 2007-06-28
ES2286237T3 (es) 2007-12-01
CA2437994C (en) 2011-05-17
RU2256666C2 (ru) 2005-07-20
CZ20032111A3 (cs) 2003-12-17
MXPA03007123A (es) 2003-11-18
CA2437994A1 (en) 2002-08-22
JP3748536B2 (ja) 2006-02-22
ZA200306121B (en) 2005-01-26
NZ527393A (en) 2004-07-30
CY1106685T1 (el) 2012-05-23
AU2002230164B2 (en) 2005-04-07
EP1364959A4 (en) 2004-03-24
IL157216A0 (en) 2004-02-19
RU2003124648A (ru) 2005-02-27
HUP0303159A2 (hu) 2003-12-29
DE60220024T2 (de) 2007-11-22
PT1364959E (pt) 2007-07-23
CN100408591C (zh) 2008-08-06
EP1364959B1 (en) 2007-05-09
BRPI0207102A8 (pt) 2018-02-27
DE60220024D1 (en) 2007-06-21
WO2002064609A1 (fr) 2002-08-22
JP2006008699A (ja) 2006-01-12
IL157216A (en) 2008-03-20
CZ303241B6 (cs) 2012-06-13
HU229294B1 (en) 2013-10-28
EP1364959A1 (en) 2003-11-26
KR20030081424A (ko) 2003-10-17

Similar Documents

Publication Publication Date Title
CY1106685T1 (el) Κρυσταλλος παραγωγου πυριμιδινο νουκλεοζιτη
BR0210030A (pt) Derivado de fenilpiridinacarbonilpiperazina
CY1106132T1 (el) Παραγωγα πιπepιδινης ως αναστολεις καναλιου καλιου
CY1106247T1 (el) Θειοφαινο- και θειαζολοσουλφοναμιδες ως αντινεοπλαστικοι παραγοντες
DK1442024T3 (da) Aminobenzamidderivater som glycogensystasekinase 3 beta-inhibitorer
UY28290A1 (es) Compuestos farmacéuticos novedosos
BR0214268A (pt) Aperfeiçoamentos em relação a abrilhantadores ópticos
NO20041503L (no) Pyrimidinoner som melanin konsentrerende hormon reseptor 1
CY1110933T1 (el) 5,7-διαμινοπυραζολο[4,3-d]πυριμιδινες με ανασταλτικη της pde-5 δραστικοτητα
ATE491703T1 (de) Phthalazinonderivate
CY1111759T1 (el) Ενδιαμεσες ενωσεις για την παρασκευη συγκεκριμενων τριαζολοπυριμιδινων ως ρ2τ ανταγωνιστων
DK2251319T3 (da) Fremgangsmåde til fremstilling af derivater af benzoesyre
ATE431827T1 (de) Phosphonocephem-verbindung
CY1110319T1 (el) Ενωσεις 7-φενυλ πυραζολοπυριδινης
TR200200100T2 (tr) Kristalin 1-metilkarbapenem türevleri.
SE0103710D0 (sv) Compounds
UY27250A1 (es) Fenil-heterociclil-cteres
DK1209151T3 (da) 4-substituerede piperidinderivativer
ES2185599T3 (es) Preparacion de intermediarios de la imidazodiacepina.
DK1140932T3 (da) Derivater af benzo-1,8-naphtyridin
DE60230924D1 (de) 2-substituierte vitamin-d-derivate
UY26778A1 (es) Derivados de ácido heteroarilalcanoico.